Skip to content

AVID BIOSERVICES, INC.

CIK 0000704562

← back to feed
Revenue (TTM)
$132.87M
−6.3% YoY Q2 Dec 2024
Net Income (TTM)
−$38.47M
−54,444.8% YoY Q2 Dec 2024
EPS Diluted (TTM)
−$0.60
Q2 Dec 2024
Gross Margin
1.0%
Q2 Dec 2024
Operating Margin
-22.8%
Q2 Dec 2024
Net Margin
-29.0%
Q2 Dec 2024
Free Cash Flow (TTM)
−$42.48M
Q2 Dec 2024
Cash
$33.42M
Q2 Dec 2024
Total Debt
$53.21M
Q2 Dec 2024
Shares Outstanding
63.96M sh
Q2 Dec 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings